Magnetic nanoparticles as contrast agents in biomedical imaging: Recent advances in iron- and manganese-based magnetic nanoparticles

Drug Metabolism Reviews

Volumn 46, Issue 2, 2014, Pages 142-154

  Felton, Charlette ^a   Karmakar, Alokita ^b   Gartia, Yashraj ^a   Ramidi, Punnamchandar ^a   Biris, Alexandru S ^b   Ghosh, Anindya ^a  

^a Department of Chemistry University of Arkansas at Little Rock ^*  (United States)

^b UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

Author keywords

Diagnosis; Imaging techniques; in vitro and in vivo; Magnetic resonance; Selectivity; Superparamagnetic nanomaterials

Indexed keywords

CONTRAST MEDIUM; MAGNETIC NANOPARTICLE; MANGANESE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; FERRIC ION; FERRIC OXIDE; MAGNETITE NANOPARTICLE; MANGANESE DERIVATIVE; MANGANESE OXIDE; OXIDE;

BIOMEDICAL IMAGING; CELL TRANSFER; CELL TRANSPORT; DIAGNOSTIC IMAGING; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL CHEMISTRY; REVIEW; ANIMAL; CHEMISTRY; DIAGNOSTIC USE; DRUG DELIVERY SYSTEM; NANOMEDICINE; PROCEDURES;

ANIMALS; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MANGANESE COMPOUNDS; NANOMEDICINE; OXIDES;

EID: 84899441469     PISSN: 03602532     EISSN: 10979883     Source Type: Journal    
DOI: 10.3109/03602532.2013.876429     Document Type: Review

References (99)

1. Achraf AF, Katarzyna C, Ghislaine L, et al. (2009). In vivo imaging of carbon nanotube biodistribution using magnetic resonance imaging. Nano Lett 9: 1023-1027.
2. Alger JR, Frank JA. (1992). The utilization of magnetic resonance imaging in physiology. Annu Rev Physiol 54: 827-846.
3. Arruebo M, Fernández-Pacheco R, Ibarra MR, Santamaría J. (2007). Magnetic nanoparticles for drug delivery. Nano Today 2: 22-32.
4. Babes L, Denizot B, Tanguy G, et al. (1999). Synthesis of iron oxide nanoparticles used as MRI contrast agents: A parametric study. J Colloid Interf Sci 212: 474-482.
5. Bae KH, Lee K, Kim C, Park G. (2011). Surface functionalized hollow manganese oxide nanoparticles for cancer targeted siRNA delivery and magnetic resonance imaging. Biomaterials 32: 176-184.
6. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I. (1994). Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 180: 53-66.
7. Bhirde AA, Patel V, Gavard JL, et al. (2009). Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano 3: 307-316.
8. Boutry S, Laurent S, Elst LV, Muller RN. (2006). Specific E-selection targeting with a superparamagnetic MRI contrast agent. Contrast Media Mol I 1: 15-22.
9. Burns AA, Vider J, Ow H, et al. (2009). Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett 9: 442-448.
10. Chan CK, Peng H, Liu G, et al. (2007). High-performance lithium battery anodes using silicon nanowires. Nat Nanotechnol 3: 31-35.
11. Choi JH, Nguyen FT, Barone PW, et al. (2007). Multimodal biomedical imaging with asymmetric single-walled carbon nanotube/iron oxide nanoparticle complexes. Nano Lett 7: 861-867.
12. Chomoucka J, Drbohlavova J, Huska D, et al. (2010). Magnetic nanoparticles and targeted drug delivering. Pharmaco Res 62: 144-149.
13. Chouly C, Pouliquen D, Lucet I, et al. (1996). Development of superparamagnetic nanoparticles for MRI: Effect of particle size, charge and surface nature on biodistribution. J Microencapsul 13: 245-255.
14. Chung HJ, Lee H, Bae K, et al. (2011). Facile synthetic route for surface-functionalized magnetic nanoparticles: Cell labeling and magnetic resonance imaging studies. ACS Nano 5: 4329-4336.
15. Colombo M, Corsi F, Foschi D, et al. (2010). HER2 targeting as a twosided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches. Pharmacol Res 62: 150-165.
16. Conlan R, Ernst R, Hahn EL, et al. (2002). A life-saving window on the mind and body: The development of magnetic resonance imaging. Nat Acad Sci 1: 1-8.
17. Cromer Berman SM, Walczak P, Bulte JW. (2011). Tracking stem cells using magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 3: 343-355.
18. Da Silva FR, Erdtmann B, Dalpiaz T, et al. (2010). Effects of dermal exposure to Nicotiana tabacum (Jean Nicot, 1560) leaves in mouse evaluated by multiple methods and tissues. J Agric Food Chem 58: 9868-9874.
19. Dalsin JL, Lin L, Tosatti S, et al. (2005). Protein resistance of titanium oxide surfaces modified by biologically inspired mPEG-DOPA. Langmuir 21: 640-646.
20. Dillon AC, Jones KM, Bekkedahl TA, et al. (1997). Storage of hydrogen in single-walled carbon nanotubes. Nature 386: 377-379.
21. El-Dakdouki MH, El-Boubbou K, Zhu DC, Huang, X. (2011). A simple method for the synthesis of hyaluronic acid coated magnetic nanoparticles for highly efficient cell labeling and in vivo imaging. RSC Adv 1: 1449-1452.
22. Elizondo G, Fretz CJ, Stark DD, et al. (1991). Preclinical evaluation of MnDPDP: New paramagnetic hepatobliliary contrast agent for MR imaging. Radiology 178: 73-78.
23. Escribano E, Fernández-Pacheco R, Valdivia JG, et al. (2012). Effect of magnet implant on iron biodistribution of Fe@C nanoparticles in the mouse. Arch Pharm Res 35: 93-100.
24. Gossuin Y, Gillis P, Hocq A, et al. (2009). Magnetic resonance relaxation properties of superparamagnetic particles. Wileys Interdiscipl Rev: Nanomed Nanobiotech 1: 299-310.
25. Gossuin Y, Roch A, Muller Robert N, Gillis P. (2002). An evaluation of the contributions of diffusion and exchange in relaxation enhancement by MRI contrast agents. J Magnet Res 158: 36-42.
26. Guo Q, Liu Y, Xu K, et al. (2013). Mouse lymphatic endothelial cell targeted probes: Anti-LYVE-1 antibody-based magnetic nanoparticles. Int J Nanomed 8: 2273-2284.
27. Gupta AK, Gupta M. (2005). Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26: 3995-4021.
28. Hong SC, Lee JH, Lee J, et al. (2011). Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups. Int J Nanomed 6: 3219-3231.
29. Huang CC, Khu NH, Yeh CS. (2010). The characteristics of sub 10 nm manganese oxide T1 contrast agents of different nanostructured morphologies. Biomaterials 31: 4073-4078.
30. Jemal A, Siegel R, Ward E, et al. (2009). Cancer statistics. CA Cancer J Clin 59: 225-249.
31. Jeyarama SA, Michael LM, Annie MT, et al. (2009). Single-walled carbon nanotube materials as T2-weighted MRI contrast agents. J Phys Chem C 113: 19369-19372.
32. Jia NQ, Lian Q, Shen HB, et al. (2007). Intracellular delivery of quantum dots tagged antisense oligodeoxynucleotides by funcationalized multiwalled carbon nanotubes. Nano Lett 7: 2976-2980.
33. Kamaly N, Kalber T, Thanou M, et al. (2009). Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging. Bioconjugate Chem 20: 648-655.
34. Karmakar A, Bratton SM, Dervishi E, et al. (2011a). Ethylenediamine functionalized-single-walled nanotube (f-SWNT)-assisted in vitro delivery of the oncogene suppressor p53 gene to breast cancer MCF-7 cells. Int J Nanomed 6: 1045-1055.
35. Karmakar A, Iancu C, Bartos DM, et al. (2012). Raman spectroscopy as a detection and analysis tool for in vitro specific targeting of pancreatic cancer cells by EGF-conjugated, single-walled carbon nanotubes. J App Toxicol 32: 365-375.
36. Karmakar A, Xu Y, Mahmood MW, et al. (2011b). Radio-frequency induced in vitro thermal ablation of cancer cells by EGF functionalized carbon-coated magnetic nanoparticles. J Mater Chem 21: 12761-12769.
37. Kievit FM, Stephen ZR, Veiseh O, et al. (2012). Targeting of primary breast cancers and metastases in a transgenic mouse model using rationally designed multifunctional SPIONs. ACS Nano 6: 2591-2601.
38. Kievit FM, Zhang M. (2011). Cancer nanoteheranostics: Improving imaging and therapy by targeted delivery across biological barriers. Avd Mater 23:H217-H247.
39. Kim T, Momin E, Choi J, et al. (2011). Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells. J Am Chem Soc 133: 2955-2961.
40. Kim, T, Reis L, Rajan K, Shima M. (2005). Magnetic behavior of iron oxide nanoparticle biomolecule assembly. J Magn Magn Mater 295: 132-138.
41. Krishnan KM. (2010). Biomedical nanomagnetics: A spin through possibilities in imaging, diagnostics, and therapy. IEEE Tran Magn 46: 2523-2558.
42. Lalatonne Y, Richardi J, Pileni M. (2004). Van der Waals versus dipolar forces controlling mesoscopic organizations of magnetic nanocrystals. Nan Mater 3: 121-125.
43. Lapcik LJ, Lapcik L, De Smedt S, et al. (1998). Hyaluronan: Preparation, structure, properties, and applications. Chem Rev 98: 2663-2683.
44. Lauffer RB. (1987). Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: Theory and design. Chem Rev 87: 901-927.
45. Lee H, Dellatore SM, Miller WM, Messersmith PB. (2007a). Musselinspired surface chemistry for multifunctional coatings. Science 318: 426-430.
46. Lee H, Yu MK, Park S, et al. (2007b). Thermally cross-linked superparamagnetic iron oxide nanoparticles: Synthesis and application as a dual imaging probe for cancer in vivo. J Am Chem Soc 129: 12739-12745.
47. Lee JH, Huh YM, Jun YW, et al. (2007c). Artificially engineered magnetic nanoparticle for ultra-sensitive molecular imaging. Nat Med 13: 95-99.
48. Li H, El-Dakdouki MH, Zhu DC, et al. (2012). Synthesis of b-cyclodextrin conjugated superparamagnetic iron oxide nanoparticles for selective binding and detection of cholesterol crystals. Chem Commun 48: 3385-3387.
49. Liu Z, Tabakman SM, Chen Z, Dai HJ. (2009). Preparation of carbon nanotube bioconjugates for biomedical applications. Nat Prot 4: 1372-1382.
50. Lu CW, Hung Y, Hsiao JK, et al. (2007). Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling. Nano Lett 7: 149-154.
51. Massart R. (1981). Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans Magn 17: 1247-1248.
52. McBain S, Yiu H, Dobson J. (2008). Magnetic nanoparticles for gene and drug delivery. Int J Nanomed 3: 159-180.
53. McCarthy JR, Weissleder R. (2008). Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 60: 1241-1251.
54. Mikhaylov G, Vasiljeva O. (2011). Promising approaches in using magnetic nanoparticles in oncology. Biol Chem 392: 955-960.
55. Misra S, Heldin P, Hascall VC, et al. (2011). Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J 278: 1429-1443.
56. Miyawaki J, Yudasak M, Imai H, et al. (2006). In vivo magnetic resonance imaging of single-walled carbon nanohorns by labeling with magnetite nanoparticles. Adv Mater 18: 1010-1014.
57. Modo M, Hoehn M, Bulte JW. (2005). Cellular MR imaging. Mol Imaging 4: 143-164.
58. Moore A, Weissleder R, Bogdanov A. (1997). Uptake of dextran-coated monocrystalline iron oxides in tumore cells and macrophages. J Magn Reson Imaging 7: 1140-1145.
59. Mulder WJM, Strijkers GJ, van Tilborg GAF, et al. (2006). Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed 19: 142-164.
60. Müller RH, Jakobs C, Kayser O. (2001). Nanosuspensions as particulate drug formulations in therapy-Rational for development and what we can expect for the future. Adv Drug Deliv Rev 47: 3-19.
61. Namiki Y, Namiki T, Yoshida H, et al. (2009). A novel magnetic crystallipid nanostructure for magnetically guided in vivo gene delivery. Nat Nanotechnol 4: 598-606.
62. Nasongkla N, Bey E, Ren J, et al. (2006). Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett 6: 2427-2430.
63. Pankhurst Q, Connolly J, Joes S, Dobson J. (2003). Applications of magnetic nanoparticles in biomedicine. J Phys D: Appl Phys 36:167-181.
64. Park J, An K, Hwang Y, et al. (2004). Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater 3: 891-895.
65. Patolsky F, Zheng G, Lieber CM. (2006). Nanowire sensors for medicine and the life sciences. Nanomedicine-UK 1: 51-65.
66. Pawelczyk E, Jordan EK, Balakumaran A, et al. (2009). In vivo transfer of intracellular labels from locally implanted bone marrow stromal cells to resident tissue macrophages. PLoS One 4:e6712.
67. Piao Y, Burns A, Kim J, et al. (2008). Designed fabrication of silicabased nanostructured particle systems for nanomedicine applications. Adv Funct Mat 18: 3745-3758.
68. Prato M, Kostarelos K, Bianco A. (2008). Functionalized carbon nanotbues in drug design and discovery. Acc Chem Res 41: 60-68.
69. Qiao R, Yang C, Gao M. (2009). Superparamagnetic iron oxide nanoparticles: From preparations to in vivo MRI applications. J Mater Chem 19: 6274-6293.
70. Reiser MF, Semmler W, Hricak H. (2008). Magnetic resonance tomography. Berlin, Heidelberg: Springer, 92-113.
71. Richard C, Doan BT, Beloeil JC, et al. (2008). Noncovalent functionalization of carbon nanotubes with amphiphilic Gd3+ chelates: Toward powerful T1 and T2 MRI contrast agents. Nano Lett 8: 232-236.
72. Roduner E. (2006). Size matters: Why nanomaterials are different. Chem Soc Rev 35: 583-592.
73. Rose-Pehersson SL, Pehersson PE. (2004). Environmental applications: Sensor and sensor systems: Overview. In: Karn B, Masciangioli T, Zhang W-x, et al., eds. Nanotechnology and the environment: Applications and implications. Washington (DC): Oxford University Press, 154-156.
74. Selvan ST, Patra PK, Ang CY, Ying JY. (2007). Synthesis of silicacoated semiconductor and magnetic quantum dots and their use in the imaging of live cells. Angew Chem Int Ed 46: 2448-2452.
75. Senyei A, Widder K, Czerlinski G. (1978). Magnetic guidance of drug carrying microspheres. J Appl Phys 49: 3578-3583.
76. Shin J, Anisur RM, Ko MK, et al. (2009). Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery. Angew Chem Int Ed 48: 321-324.
77. Silva AKA, Wilhelm C, Kolosnjaj-Tabi J, et al. (2012). Cellular transfer of magnetic nanoparticles via cell microvesicles: Impact on cell tracking by magnetic resonance imaging. Pharm Res 29: 1392-1403.
78. Singh NP, McCoy MT, Tice RR, Schneider EL. (1988). A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175: 184-191.
79. Sitharaman B, Kissell KR, Hartman KB, et al. (2005). Superparamagnetic gadonanotubes are high-performance MRI contrast agents. Chem Commun 31: 3915-3917.
80. Sonvico F, Mornet S, Vasseur S, et al. (2006). Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: Synthesis, physicochemical characterization, and in vitro experiments. Bioconjugate Chem 16: 1181-1188.
81. Stöber W, Fink A, Bohn E. (1968). Controlled growth of monodisperse silica spheres in the micron size range. J Colloid Interf Sci 26: 62-69.
82. Sun SH, Zeng H, Robinson DB, et al. (2004). Monodisperse MFe2O4 (M=Fe, Co, Mn) nanoparticles. J Am Chem Soc 126: 273-279.
83. Telgmann L, Faber H, Jahn S, et al. (2012). Identification and quantification of potential metabolites of Gd-based contrast agents by electrochemistry/separation/mass spectrometry. J Chromatogr A 1240: 147-155.
84. Tran TD, Caruthers SD, Hughes M, et al. (2007). Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics. Int J Nanomed 2: 515-526.
85. Verity MA. (1999). Manganese neurotoxicity: A mechanistic hypothesis. Neurotoxicology 20: 489-497.
86. Wang Y, Wong JF, Teng X, et al. (2003). "Pulling" nanoparticles into water: Phase transfer of oleic acid stabilized monodisperse nanoparticles into aqueous solutions of a-cyclodextrin. Nano Lett 3: 1555-1559.
87. Widder KJ, Senyei AE, Scarpelli DG. (1978). Magnetic microspheres: A model system for site specific drug delivery in vivo. Exp Biol Med 158:141.
88. Wong N, Kam S, Dai HJ. (2005). Carbon nanotubes as intracellular protein transporters: Generality and biological funcationality. J Am Chem Soc 127: 6021-6026.
89. Xu Y, Karmakar A, Heberlein WE, et al. (2012). Multifunctional magnetic nanoparticles for synergistic enhancement of cancer treatment by combinatorial radio frequency thermolysis and drug delivery. Adv Healthcare Mater 1: 493-501.
90. Yang H, Zhao F, Li Y, et al. (2013). VCAM-1-targeted core/shell nanoparticles for selective adhesion and deliversy to endothelial cells with lipopolysaccharide-induced inflammation under shear flow and cellular magnetic resonance imaging in vitro. INT J Nanomed 8: 1897-1906.
91. Yellen BB, Forbes ZG, Halverson DS, et al. (2005). Targeted drug delivery to magnetic implants for therapeutic applications. J Magn Magn Mater 293: 647-654.
92. Yi DK, Selvan ST, Lee SS, et al. (2005). Silica-coated nanocomposites of magnetic nanoparticles and quantum dots. J Am Chem Soc 127: 4990-4991.
93. Yin M, Wang M, Miao F, et al. (2012). Water-dispersible multiwalled carbon nanotube/iron oxide hybrids as contrast agents for cellular magnetic resonance imaging. Carbon 50: 2162-2170.
94. Yiu HHP, Pickard MR, Olariu CI, et al. (2011). Fe3O4-PEI-RITC magnetic nanoparticles with imaging and gene transfer capability: Development of a tool for neural cell transplantation therapies. Pharm Res 29: 1328-1343.
95. Yoo, JW. (2012). Toward improved selectivity of targeted delivery: The potential of magnetic nanoparticles. Arch Pharm Res 35: 1-2.
96. Yoon T-J, Kim JS, Kim BG, et al. (2005). Multifunctional nanoparticles possessing a "Magnetic Motor Effect" for drug or gene delivery. Angew Chem Int Ed 44: 1068-1071.
97. Zhang L, Gu FX, Chan JM, et al. (2008). Nanoparticles in medicine: Therapeutic applications and developments. Clin Pharmocol Ther 83: 761-769.
98. Zhao V, Nie W, Liu X, et al. (2008). Shape- and size-controlled synthesis and dependent magnetic properties of nearly monodisperse Mn3O4 nanocrystals. Small 4: 77-81.
99. Zhdanov RI, Podobed OV, Vlassov VV. (2002). Cationic lipid-DNA complexes-lipoplexes-for gene transfer and therapy. Bioelectrochemistry 58: 53-64.